A New Form of Lithium for Improved Treatment and Minimized Side Effects

A discussion on a new lithium formulation called LiPerSAL, which combines the amino acid perylene and cell isylate to improve its ability to cross the blood brain barrier. This promising development aims to reduce physical side effects and treat conditions such as Alzheimer's disease, PTSD, major depression, and bipolar disorder.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.